FDA-Inspected Site

Octapharma Plasma Inc.

2 FDA inspections are on record for Octapharma Plasma Inc. in Sparks, United States.

483· Form 483 issued

Sparks, United States · Last updated July 11, 2026

Overview

  • 2 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2025-06-05.

At a glance

Inspections

2

Form 483s

1

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
30 May 2025 – 5 Jun 2025Biologics483View 483 →
27 Sep 2021 – 29 Sep 2021BiologicsClean

Observations on record

Form 483 observations cited at this site, most recent first.

5 Jun 2025
21 CFR 606.100(b)(2)

Donor qualifying tests & measurements

Cited by Shelley H Beausoleil

5 Jun 2025
21 CFR 630.10(a)

Donor Eligibility Factors

Cited by Shelley H Beausoleil

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 606.100(b)(2)Cited across public-safe Form 483 observations1x
21 CFR 630.10(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Octapharma Plasma Inc.'s 1 Form 483

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat

Related sites